Researchers find master gene behind blood vessel development

Feb 04, 2009

In a first of its kind discovery, University of Minnesota researchers have identified the "master gene" behind blood vessel development. Better understanding of how this gene operates in the early stages of development may help researchers find better treatments for heart disease and cancer.

Using genetically engineered mice, researchers with the University of Minnesota Medical School's Lillehei Heart Institute were able to identify a protein, Nkx2-5, which activates a certain gene, and in turn, determines the fate of a group of cells in a developing embryo.

"If we can understand the mechanism, or how certain stem cells choose a particular path, we can alter it to prevent or treat disease," said Daniel Garry, M.D., Ph.D., lead researcher, executive director of the institute, and chief of the cardiovascular division in the Department of Medicine. "This gene discovery provides the key to unlocking the secret of how blood vessels grow."

Researchers knew that certain precursor cells, or progenitor cells, become the three types of cells that make up the cardiovascular system: smooth muscle, endothelial (blood vessel), and cardiac muscle. What they didn't know, until now, is how those progenitor cells end up as one type or another. Garry likened the team's discovery to finding the recipe of how certain cells become blood vessels.

By understanding how the cells develop, Garry said they will be able to study how they might modify the gene to create a desired response.

"Next we are looking at how we could over-express the gene or knock it down," he said.

For example, in the case of heart disease or heart failure, they may be able to "turn on" the gene to make it create new, healthy blood vessels. Or, in the case of cancer, they could turn off the gene to limit blood supply to a tumor, causing it to shrink.

The research appeared in a recent issue of the Proceedings of the National Academy of Sciences.

Source: University of Minnesota

Explore further: Integrative approaches key to understanding cancer, developing therapies

add to favorites email to friend print save as pdf

Related Stories

Image: Human endothelial cells experiment bound for ISS

Feb 25, 2015

Components of human endothelial cells stained for identification. In red is the 'actin' protein that allows the cells to move, adhere, divide and react to stimuli. In blue are the cell nuclei containing DNA.

Improving imaging of cancerous tissues by reversing time

Nov 02, 2014

As a child, it was fascinating to put a flashlight up to our palms to see the light shine through the hand. Washington University in St. Louis engineers are using a similar idea to track movement inside the ...

Recommended for you

Blood test may shed new light on Fragile X related disorders

Mar 26, 2015

A blood test may shed new light on Fragile X syndrome related disorders in women, according to a new study published in the March 25, 2015, online issue of Neurology, the medical journal of the American Academy of Neurol ...

Recycling histones through transcription

Mar 26, 2015

Cells reuse a part of the histones which are used to pack DNA, according to a current study by Karolinska Institutet. The study, which is published in the journal Genome Research, was conducted on yeast cells, but it is ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.